The estimated Net Worth of Maninder Hora is at least $1.39 Milhão dollars as of 16 May 2019. Maninder Hora owns over 2,449 units of Nektar Therapeutics stock worth over $118,368 and over the last 12 years Maninder sold NKTR stock worth over $1,269,423.
Maninder has made over 20 trades of the Nektar Therapeutics stock since 2016, according to the Form 4 filled with the SEC. Most recently Maninder sold 2,449 units of NKTR stock worth $76,825 on 16 May 2019.
The largest trade Maninder's ever made was exercising 180,000 units of Nektar Therapeutics stock on 5 April 2017 worth over $2,466,000. On average, Maninder trades about 9,623 units every 38 days since 2013. As of 16 May 2019 Maninder still owns at least 94,694 units of Nektar Therapeutics stock.
You can see the complete history of Maninder Hora stock trades at the bottom of the page.
Maninder's mailing address filed with the SEC is 455 MISSION BAY BOULEVARD SOUTH, , SAN FRANCISCO, CA, 94158.
Over the last 21 years, insiders at Nektar Therapeutics have traded over $57,608,493 worth of Nektar Therapeutics stock and bought 90,000 units worth $1,628,550 . The most active insiders traders include Howard W Robin, Gil M Labrucherie, eJohn Nicholson. On average, Nektar Therapeutics executives and independent directors trade stock every 11 days with the average trade being worth of $36,648. The most recent stock trade was executed by Jonathan Zalevsky on 19 August 2024, trading 6,866 units of NKTR stock currently worth $8,788.
nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.
Nektar Therapeutics executives and other stock owners filed with the SEC include: